Ukr.Biochem.J. 2022; Volume 94, Issue 2, Mar-Apr, pp. 66-75


Application of gold nanoparticles to determine spermine in the presence of other polyamines

Yu. V. Yanish1, M. P. Prylutskyi1*, S. P. Zaletok1, Yu. P. Mukha2

1R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv;
2O. O. Chuiko Institute of Surface Chemistry, National Academy of Sciences of Ukraine, Kyiv;

Received: 19 October 2021; Accepted: 01 July 2022

The development of methods for the detection of polyamines in biological fluids is essential to improve early diagnosis and treatment of patients with prostate cancer. One of the promising areas is the use of noble metal nanoparticles. According to the literature data, there is no methodological approach have been developed to reliably distinguish spermine from other polyamines, in particular, from their acetylated forms and related compounds present in biological fluids. The paper presents the results of spectrophotometric determination of spermine both alone and in the presence of putrescine, spermidine or urea in the urine using gold nanoparticles. The results of the experiments proved that the developed method is suitable for the selective determination of spermine. It was shown that the presence of spermidine, putrescine, acetylated forms of polyamines or carbamide does not affect the results of the analysis.

Keywords: , , , ,


  1. Soda K. The mechanisms by which polyamines accelerate tumor spread. J Exp Clin Cancer Res. 2011;30(1):95. PubMed, PubMedCentral, CrossRef
  2. Berdinskikh NK, Zaletok SP. Polyamines and tumor growth. Naukova dumka, 1987. 141 p. (In Russian).
  3. Löser C, Fölsch UR, Paprotny C, Creutzfeldt W. Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer. Cancer. 1990;65(4):958-966. PubMed, CrossRef
  4. Kubota S, Okada M, Yoshimoto M, Murata N, Yamasaki Z, Wada T, Imahori K, Ohsawa N, Takaku F. Urinary polyamines as a tumor marker. Cancer Detect Prev. 1985;8(1-2):189-192. PubMed
  5. Shukla-Dave A, Castillo-Martin M, Chen M, Lobo J, Gladoun N, Collazo-Lorduy A, Khan FM, Ponomarev V, Yi Z, Zhang W, Pandolfi PP, Hricak H, Cordon-Cardo C. Ornithine decarboxylase is sufficient for prostate tumorigenesis via androgen receptor signaling. Am J Pathol. 2016;186(12):3131-3145. PubMed, PubMedCentral, CrossRef
  6. Huang W, Eickhoff JC, Mehraein-Ghomi F, Church DR, Wilding G, Basu HS. Expression of spermidine/spermine N(1) -acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis. Prostate. 2015;75(11):1150-1159. PubMed, PubMedCentral, CrossRef
  7. Zabala-Letona A, Arruabarrena-Aristorena A, Martín-Martín N, Fernandez-Ruiz S, Sutherland JD, Clasquin M, Tomas-Cortazar J, Jimenez J, Torres I, Quang P. et al. mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer. Nature. 2017;547(7661):109-113. PubMed, PubMedCentral, CrossRef
  8. Tessem MB, Bertilsson H, Angelsen A, Bathen TF, Drabløs F, Rye MB. A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer. PLoS One. 2016;11(4):e0153727. PubMed, PubMedCentral, CrossRef
  9. Andersen MK, Giskeødegård GF, Tessem MB. Metabolic alterations in tissues and biofluids of prostate cancer patients. Curr Opin Endocr Metab Res. 2020;10:23–28. CrossRef
  10. Goodwin AC, Jadallah S, Toubaji A, Lecksell K, Hicks JL, Kowalski J, Bova GS, De Marzo AM, Netto GJ, Casero RA Jr. Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. Prostate. 2008;68(7):766-772. PubMed, PubMedCentral, CrossRef
  11. Affronti HC, Rowsam AM, Pellerite AJ, Rosario SR, Long MD, Jacobi JJ, Bianchi-Smiraglia A, Boerlin CS, Gillard BM, Karasik E, Foster BA, Moser M, Wilton JH, Attwood K, Nikiforov MA, Azabdaftari G, Pili R, Phillips JG, Casero RA Jr, Smiraglia DJ. Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy. Nat Commun. 2020;11(1):52. PubMed, PubMedCentral, CrossRef
  12. Sun L, Yang J, Qin Y, Wang Y, Wu H, Zhou Y, Cao C. Discovery and antitumor evaluation of novel inhibitors of spermine oxidase. J Enzyme Inhib Med Chem. 2019;34(1):1140-1151. PubMed, PubMedCentral, CrossRef
  13. Bentrad VV, Zaletok SP, Klenov OO, Vitruk YuV, Stakhovsky E.O. Gene expression of polyamine metabolism proteins in human prostate cancer and benign prostatic hyperplasia. Oncology. 2020;22(1–2):32-35.
  14. Lynch MJ, Nicholson JK. Proton MRS of human prostatic fluid: correlations between citrate, spermine, and myo-inositol levels and changes with disease. Prostate. 1997;30(4):248-255. PubMed, CrossRef
  15. Serkova NJ, Gamito EJ, Jones RH, O’Donnell C, Brown JL, Green S, Sullivan H, Hedlund T, Crawford ED. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate. 2008;68(6):620-628. PubMed, CrossRef
  16. Tsoi TH, Chan CF, Chan WL, Chiu KF, Wong WT, Ng CF, Wong KL. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers. PLoS One. 2016;11(9):e0162217. PubMed, PubMedCentral, CrossRef
  17. Kdadra M, Höckner S, Leung H, Kremer W, Schiffer E. Metabolomics Biomarkers of Prostate Cancer: A Systematic Review. Diagnostics (Basel). 2019;9(1):21. PubMed, PubMedCentral, CrossRef
  18. Akshaya K, Arthi C, Pavithra AJ , Poovizhi P, Antinate SS, Hikku GS, Jeyasubramanian K, Murugesan R. Bioconjugated gold nanoparticles as an efficient colorimetric sensor for cancer diagnostics. Photodiagnosis Photodyn Ther. 2020;30:101699. PubMed, CrossRef
  19. Singh P, Pandit S, Mokkapati VRSS, Garg A, Ravikumar V, Mijakovic I. Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer. Int J Mol Sci. 2018;19(7):1979. PubMed, PubMedCentral, CrossRef
  20. António M, Vitorino R, Daniel-da-Silva AL. Gold nanoparticles-based assays for biodetection in urine. Talanta. 2021;230:122345. PubMed, PubMedCentral, CrossRef
  21. Zaletok SP, Klenov OO, Gogol SV, Bentrad VV, Stakhovsky EO, Vitruk YuU, Grechko BO. Blood and urine polyamines as new diagnostic markers of prostate cancer. Oncology. 2019;21(3):219-223. (In Ukrainian). CrossRef
  22. Fletcher JT, Bruck BS. Spermine detection via metal-mediated ethynylarene ‘turn-on’ fluorescence signaling. Sens Actuators B Chem. 2015;207(Pt A):843-848. PubMed, PubMedCentral, CrossRef
  23. Jornet-Martínez N, González-Béjar M, Moliner-Martínez Y, Campíns-Falcó P, Pérez-Prieto J. Sensitive and selective plasmonic assay for spermine as biomarker in human urine. Anal Chem. 2014;86(3):1347-1351. PubMed, CrossRef
  24. Checkman IS., Pryskoka AO. Nanogold and nanocoatings: state scientific investigation prospects in medical application. Ukr Med J. 2010;2(76): 37-43. (In Ukrainian).
  25. Kimling J, Maier M, Okenve B, Kotaidis V, Ballot H, Plech A. Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B. 2006;110(32):15700-15707. PubMed, CrossRef
  26. Katifelis H, Lyberopoulou A, Mukha I, Vityuk N, Grodzyuk G, Theodoropoulos GE, Efstathopoulos EP, Gazouli M. Ag/Au bimetallic nanoparticles induce apoptosis in human cancer cell lines via P53, CASPASE-3 and BAX/BCL-2 pathways. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S389-S398. PubMed, CrossRef
  27. Suzuki I, Ogawa M, Seino K, Nogawa M, Naito H, Yamakoshi K I, Tanaka S. Reagentless Estimation of Urea and Creatinine Concentrations Using Near-Infrared Spectroscopy for Spot Urine Test of Urea-to-Creatinine Ratio. Adv Biomed Eng. 2018;7:72–81.CrossRef
  28. Casero RA Jr, Murray Stewart T, Pegg AE. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat Rev Cancer. 2018;18(11):681-695. PubMed, PubMedCentral, CrossRef
  29. Bae DH, Lane DJR, Jansson PJ, Richardson DR. The old and new biochemistry of polyamines. Biochim Biophys Acta Gen Subj. 2018;1862(9):2053-2068. PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.